Clinic
Highland Clinic, a Prof Med Corp
Highland Clinic, a Prof Med Corp was paid $5.85M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoHIGHLAND CLINIC, A PROF MED CORP
SHREVEPORT, LA 71105
SHREVEPORT, LA 71105
33aNPI1053315846assigned 06/09/2005
33bProvider typeClinic/Center
28Total paid$5.85M
24GClaims212,266
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Louisiana
Rank by total paid#5 of 112
Median peer was paid$138K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,342 | $953K | |
| 2019 | 35,568 | $879K | |
| 2020 | 25,586 | $709K | |
| 2021 | 29,117 | $736K | |
| 2022 | 32,232 | $837K | |
| 2023 | 30,009 | $878K | |
| 2024incomplete | 23,412 | $857K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 30,851 | 23,560 | $1.14M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 26,414 | 19,347 | $866K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 9.6% | 9,408 | 7,741 | $562K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 7.9% | 5,840 | 5,057 | $460K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 5.9% | 2,583 | 1,793 | $343K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.8% | 3,921 | 3,045 | $283K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.6% | 6,273 | 3,111 | $208K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.9% | 3,079 | 2,434 | $167K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.8% | 2,116 | 1,918 | $165K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 4,163 | 2,927 | $140K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 2.2% | 819 | 638 | $130K |
| 92250 | 2.1% | 5,049 | 3,421 | $122K |
100 more codes
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 1.8% | 184 | $103K |
| 92060 | 1.6% | 3,583 | $95K | |
| 95117 | 1.6% | 12,788 | $94K | |
| 76801 | 1.5% | 1,230 | $88K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 2,152 | $69K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 1,272 | $68K |
| 59430 | 1.1% | 745 | $67K | |
| 59514 | 1.1% | 149 | $64K | |
| 99205 | Prolong outpt/office vis | 1.1% | 802 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 15,801 | $61K |
| 80053 | Comprehensive metabolic panel | 1.0% | 12,310 | $60K |
| 92285 | <1% | 3,483 | $49K | |
| 82728 | <1% | 5,687 | $37K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 773 | $32K |
| 94010 | <1% | 1,597 | $28K | |
| 83550 | <1% | 5,723 | $24K | |
| 99223 | Prolong inpt eval add15 m | <1% | 234 | $23K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 564 | $21K |
| 94060 | <1% | 808 | $20K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 1,504 | $19K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 256 | $16K |
| 83540 | <1% | 5,722 | $15K | |
| 94664 | <1% | 2,454 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 552 | $13K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 257 | $12K |
| 96417 | <1% | 796 | $11K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 138 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,857 | $7K |
| 95012 | <1% | 735 | $7K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 489 | $6K |
| 82950 | <1% | 1,395 | $5K | |
| 54150 | <1% | 38 | $5K | |
| 82607 | <1% | 642 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 472 | $4K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 64 | $3K |
| 83615 | <1% | 1,181 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 16 | $3K |
| 95024 | <1% | 509 | $3K | |
| 80050 | General health panel | <1% | 118 | $3K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 61 | $3K |
| 98960 | <1% | 929 | $2K | |
| 96367 | <1% | 854 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 941 | $2K |
| 96160 | <1% | 169 | $2K | |
| 95115 | <1% | 285 | $2K | |
| 76820 | <1% | 31 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 52 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,798 | $1K |
| 73562 | <1% | 147 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,473 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 752 | $1K |
| 96401 | <1% | 137 | $911.45 | |
| 90688 | <1% | 116 | $820.98 | |
| 92567 | <1% | 64 | $810.11 | |
| 84439 | <1% | 133 | $808.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 77 | $735.04 |
| 89190 | <1% | 256 | $676.94 | |
| 82746 | <1% | 125 | $672.98 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 54 | $667.44 |
| 81001 | <1% | 338 | $664.94 | |
| 86140 | <1% | 709 | $606.41 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 436 | $524.77 |
| 96415 | <1% | 38 | $515.25 | |
| J9045 | Injection, carboplatin, 50 mg | <1% | 20 | $509.72 |
| 96377 | <1% | 112 | $499.84 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 820 | $425.61 |
| 87660 | <1% | 34 | $409.80 | |
| 87510 | <1% | 34 | $407.35 | |
| 87480 | <1% | 34 | $407.35 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 69 | $407.25 |
| 84702 | <1% | 41 | $383.36 | |
| 85652 | <1% | 707 | $318.11 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 79 | $262.77 |
| 92015 | Determination of refractive state | <1% | 160 | $254.24 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 115 | $250.79 |
| 82378 | <1% | 16 | $226.56 | |
| 80061 | Lipid panel | <1% | 72 | $205.09 |
| 20610 | <1% | 80 | $192.38 | |
| 73030 | <1% | 87 | $176.67 | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 26 | $175.01 |
| 84481 | <1% | 21 | $157.12 | |
| 92202 | <1% | 33 | $152.13 | |
| 73630 | <1% | 13 | $98.00 | |
| 92083 | <1% | 17 | $69.45 | |
| 81025 | <1% | 17 | $66.91 | |
| 73560 | <1% | 18 | $37.64 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 40 | $34.24 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 852 | $7.86 |
| J3490 | Unclassified drugs | <1% | 638 | $6.60 |
| 85007 | <1% | 58 | $2.49 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 1,493 | $0.00 |
| 1126F | 0% | 349 | $0.00 | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 0% | 87 | $0.00 |
| 99024 | 0% | 53 | $0.00 | |
| J2505 | Injection, pegfilgrastim, 6 mg | 0% | 32 | $0.00 |
| 1125F | 0% | 84 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 28 | $0.00 |
| 73502 | 0% | 16 | $0.00 | |
| 1160F | 0% | 670 | $0.00 | |
| 1159F | 0% | 670 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DEBBIE (ADMINISTRATOR)